Press Release, Lund February 5, 2020 Alpha1H shows significant promise as a new and effective cancer drug with low toxicity in a clinical bladder cancer…
Read More
Pressmeddelande, Lund 3 februari, 2020 Hamlet Pharma tillförs 12,95 miljoner SEK genom inlösen av teckningsoptioner utfärdade i samband med den riktade emissionen från den 1…
Dose-escalation studies have been performed to find the optimal dose of Alpha1H for future therapeutic studies. In the murine bladder cancer model, we observed a…
The Board of Hamlet Pharma AB has decided on a new date for the Annual General Meeting. The new date of the Annual General Meeting is Thursday,…
With Hamlet,from breast milk and the “foundation of life”to cancer therapy that improves the quality of life World Breastfeeding Week 2018 begins today, a worldwide,…
HAMLET Pharma has formally appointed Prof Catharina Svanborg, Chairman and founder of HAMLET Pharma, as Chief Medical Officer (CMO), to enable her to continue her…